Sanofi Pasteur’s Five-In-One Vaccine Approved
This article was originally published in The Pink Sheet Daily
Executive Summary
Next step for Pentacel is the June 25 ACIP Vaccines for Children vote.
You may also be interested in...
Sanofi-Aventis To File For Menactra Use In Infants
Firm sees pharmacoeconomic advantage for two-dose regimen at nine and 12 months.
Sanofi-Aventis To File For Menactra Use In Infants
Firm sees pharmacoeconomic advantage for two-dose regimen at nine and 12 months.
Sanofi Pentacel Revised Action Date Is Nov. 2
FDA extends the combination vaccine’s action date for the second time, this time requesting lab validation information relating to the pertussis component, but not directly related to Pentacel.